Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-03-24
DOI
10.3389/fphar.2015.00057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Switching and withdrawing hormonal agents for castration-resistant prostate cancer
- (2015) David Lorente et al. Nature Reviews Urology
- Androgen receptor: structure, role in prostate cancer and drug discovery
- (2014) MH Eileen Tan et al. ACTA PHARMACOLOGICA SINICA
- Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer
- (2014) Ravi S.N. Munuganti et al. CHEMISTRY & BIOLOGY
- Strategies for targeting the androgen receptor axis in prostate cancer
- (2014) Brett S. Carver DRUG DISCOVERY TODAY
- Targeting the androgen receptor in prostate cancer
- (2014) Zoran Culig EXPERT OPINION ON PHARMACOTHERAPY
- A New Avenue toward Androgen Receptor Pan-antagonists: C2 Sterically Hindered Substitution of Hydroxy-propanamides
- (2014) Andrea Guerrini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the Androgen Receptor with Steroid Conjugates
- (2014) Paul M. Levine et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
- (2014) Huifang Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor
- (2014) Jeanny B. Aragon-Ching Frontiers in Oncology
- Selectively Targeting Prostate Cancer with Antiandrogen Equipped Histone Deacetylase Inhibitors
- (2013) Berkley E. Gryder et al. ACS Chemical Biology
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- The hurdle of antiandrogen drug resistance: drug design strategies
- (2013) Jill A Trendel Expert Opinion on Drug Discovery
- Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
- (2013) Nada Lallous et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synthesis and Structure–Activity Relationship Studies of Novel Dihydropyridones as Androgen Receptor Modulators
- (2013) Antonella Pepe et al. JOURNAL OF MEDICINAL CHEMISTRY
- SAR Based Design of Nicotinamides as a Novel Class of Androgen Receptor Antagonists for Prostate Cancer
- (2013) Su Hui Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer
- (2013) Huifang Li et al. MOLECULAR CANCER THERAPEUTICS
- NF- B2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants
- (2013) N. Nadiminty et al. MOLECULAR CANCER THERAPEUTICS
- Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer
- (2013) Preethi Ravindranathan et al. Nature Communications
- A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
- (2013) J. D. Joseph et al. Cancer Discovery
- Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
- (2013) Jenny Persson et al. Drug Design Development and Therapy
- Designer antiandrogens join the race against drug resistance
- (2013) Jatinder S Josan et al. eLife
- Overcoming mutation-based resistance to antiandrogens with rational drug design
- (2013) Minna D Balbas et al. eLife
- Antiandrogen Gold Nanoparticles Dual-Target and Overcome Treatment Resistance in Hormone-Insensitive Prostate Cancer Cells
- (2012) Erik C. Dreaden et al. BIOCONJUGATE CHEMISTRY
- Drug-conjugated antibodies for the treatment of cancer
- (2012) John M. Lambert BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Structure-based methods for predicting target mutation-induced drug resistance and rational drug design to overcome the problem
- (2012) Ge-Fei Hao et al. DRUG DISCOVERY TODAY
- Structure-based Virtual Screening and Identification of a Novel Androgen Receptor Antagonist
- (2012) Chin-Hee Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multivalent Peptidomimetic Conjugates: A Versatile Platform for Modulating Androgen Receptor Activity
- (2012) Paul M. Levine et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Beyond the Ligand-Binding Pocket: Targeting Alternate Sites in Nuclear Receptors
- (2012) Laura Caboni et al. MEDICINAL RESEARCH REVIEWS
- In SilicoDiscovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate Cancer
- (2012) Howard C. Shen et al. MOLECULAR ENDOCRINOLOGY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Mechanism of Androgen Receptor Antagonism by Bicalutamide in the Treatment of Prostate Cancer
- (2011) D. J. Osguthorpe et al. BIOCHEMISTRY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Androgen Deprivation Therapy as Primary Treatment for Prostate Cancer
- (2011) Dara H. Cannata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Unexpected Binding Orientation of Bulky-B-Ring Anti-Androgens and Implications for Future Drug Targets
- (2011) Charles B. Duke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitors of Androgen Receptor Activation Function-2 (AF2) Site Identified through Virtual Screening
- (2011) Peter Axerio-Cilies et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent developments in antiandrogens and selective androgen receptor modulators
- (2011) Bernard Haendler et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Androgen receptor as a therapeutic target
- (2010) Wenqing Gao ADVANCED DRUG DELIVERY REVIEWS
- Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
- (2010) Raymond J. Andersen et al. CANCER CELL
- An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(ii) metallo-drug
- (2010) Martin Huxley et al. DALTON TRANSACTIONS
- Design and Synthesis of Androgen Receptor Full Antagonists Bearing ap-Carborane Cage: Promising Ligands for Anti-Androgen Withdrawal Syndrome
- (2010) Tokuhito Goto et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dynamic communication between androgen and coactivator: Mutually induced conformational perturbations in androgen receptor ligand-binding domain
- (2010) Xue Xu et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Structural basis for computational screening of non-steroidal androgen receptor ligands
- (2009) Tommi H Nyrönen et al. Expert Opinion on Drug Discovery
- Design and Synthesis of Androgen Receptor Antagonists with Bulky Side Chains for Overcoming Antiandrogen Resistance
- (2009) Jinming Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Study of the impact of the T877A mutation on ligand-induced helix-12 positioning of the androgen receptor resulted in design and synthesis of novel antiandrogens
- (2009) Jinming Zhou et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring
- (2008) Kiminori Ohta et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Antiandrogen withdrawal in castrate-refractory prostate cancer
- (2008) A. Oliver Sartor et al. CANCER
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
- (2008) R. B. Montgomery et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started